Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Gross Margin (2022 - 2025)

Historic Gross Margin for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to 254.34%.

  • Lucid Diagnostics' Gross Margin fell 82600.0% to 254.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 269.05%, marking a year-over-year increase of 336200.0%. This contributed to the annual value of 278.81% for FY2024, which is 2968100.0% up from last year.
  • As of Q3 2025, Lucid Diagnostics' Gross Margin stood at 254.34%, which was down 82600.0% from 233.92% recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Gross Margin peaked at 100.0% during Q3 2022, and registered a low of 4375.89% during Q4 2022.
  • In the last 4 years, Lucid Diagnostics' Gross Margin had a median value of 321.41% in 2023 and averaged 739.77%.
  • Examining YoY changes over the last 5 years, Lucid Diagnostics' Gross Margin showed a top increase of 40520500bps in 2023 and a maximum decrease of -7301000bps in 2023.
  • Lucid Diagnostics' Gross Margin (Quarter) stood at 4375.89% in 2022, then soared by 93bps to 323.85% in 2023, then grew by 28bps to 234.5% in 2024, then fell by -8bps to 254.34% in 2025.
  • Its Gross Margin stands at 254.34% for Q3 2025, versus 233.92% for Q2 2025 and 391.43% for Q1 2025.